Abiopharma

🔍 GOLDSMITH MARK A (Executive)

Company: Revolution Medicines, Inc. (RVMD)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 80,000 shares of Common Stock at $4.73 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: false | shares_owned_after: 347,330.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,128 shares of Common Stock at $207.233 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 342,202.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 24,917 shares of Common Stock at $208.3697 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 317,285.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 35,938 shares of Common Stock at $209.2615 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 281,347.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 3,813 shares of Common Stock at $210.2466 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 277,534.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 6,583 shares of Common Stock at $211.3331 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 270,951.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 3,621 shares of Common Stock at $212.0776 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 267,330.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 190 shares of Common Stock at $207.2454 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 64,234.00 | transaction_form_type: 4 | Footnotes: F9, F10
• Sold 951 shares of Common Stock at $208.3648 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 63,283.00 | transaction_form_type: 4 | Footnotes: F11, F10
• Sold 1,351 shares of Common Stock at $209.2812 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,932.00 | transaction_form_type: 4 | Footnotes: F12, F10
• Sold 136 shares of Common Stock at $210.4017 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,796.00 | transaction_form_type: 4 | Footnotes: F13, F10
• Sold 245 shares of Common Stock at $211.4651 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,551.00 | transaction_form_type: 4 | Footnotes: F14, F10
• Sold 127 shares of Common Stock at $212.0635 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,424.00 | transaction_form_type: 4 | Footnotes: F15, F10
• Sold 177 shares of Common Stock at $207.2515 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 64,247.00 | transaction_form_type: 4 | Footnotes: F9, F16
• Sold 937 shares of Common Stock at $208.3609 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 63,310.00 | transaction_form_type: 4 | Footnotes: F17, F16
• Sold 1,405 shares of Common Stock at $209.2664 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,905.00 | transaction_form_type: 4 | Footnotes: F18, F16
• Sold 126 shares of Common Stock at $210.403 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,779.00 | transaction_form_type: 4 | Footnotes: F13, F16
• Sold 229 shares of Common Stock at $211.4648 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,550.00 | transaction_form_type: 4 | Footnotes: F14, F16
• Sold 126 shares of Common Stock at $212.0641 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 61,424.00 | transaction_form_type: 4 | Footnotes: F15, F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: Trust | shares_owned_after: 594,060.00 | Footnotes: F19
• Sold 80,000 shares of Stock Option (Right to Buy) at $4.73 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2029-08-08 | Exercise: 2023-08-09 | equity_swap_involved: false | shares_owned_after: 344,085.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
• F2: Includes 182,938 restricted stock units.
• F3: This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F10: Held by Jonathan Goldsmith Revocable Trust.
• F11: This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F16: Held by Rebecca Goldsmith Revocable Trust.
• F17: This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F18: This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F19: Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
• REMARKS: President and Chief Executive Officer